Purification and biochemical characterization of the VIM-1 metallo-β-lactamase

被引:76
作者
Franceschini, N
Caravelli, B
Docquier, JD
Galleni, M
Frère, JM
Amicosante, G
Rossolini, GM
机构
[1] Univ Aquila, Dipartimento Sci & Tecnol Biomed, I-67100 Laquila, Italy
[2] Univ Siena, Sez Microbiol, Dipartimento Biol Mol, I-53100 Siena, Italy
[3] Univ Liege, Inst Chim, Enzymol Lab, B-4000 Liege, Belgium
[4] Univ Liege, Inst Chim, Ctr Ingn Prot, B-4000 Liege, Belgium
关键词
D O I
10.1128/AAC.44.11.3003-3007.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
VIM-1 is a new group 3 metallo-beta -lactamase recently detected in carbapenem-resistant nosocomial isolates of Pseudomonas aeruginosa from the Mediterranean area. In this work, VIM-1 was purified from an Escherichia coli strain carrying the cloned bla(VIM-1) gene by means of an anion-exchange chromatography step followed by a gel permeation chromatography step. The purified enzyme exhibited a molecular mass of 26 kDa in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and an acidic pi of 5.1 in analytical isoelectric focusing. Amino-terminal sequencing showed that mature VIM-1 results from the removal of a 26-amino-acid signal peptide from the precursor. VIM-1 hydrolyzes a broad array of beta -lactam compounds, including penicillins, narrow- to expanded-spectrum cephalosporins, carbapenems, and mechanism-based serine-beta -lactamase inactivators. Only monobactams escape hydrolysis. The highest catalytic constant/K-m ratios (>10(6) M-1 . s(-1)) were observed with carbenicillin, azlocillin, some cephalosporins (cephaloridine, cephalothin, cefuroxime, cefepime, and cefpirome), imipenem, and biapenem. Kinetic parameters showed remarkable variability with different beta -lactams and also within the various penam, cephem, and carbapenem compounds, resulting in no clear preference of the enzyme for any of these beta -lactam subfamilies. Significant differences were observed with some substrates between the kinetic parameters of VIM-1 and those of other metallo-beta -lactamases. Inactivation assays carried out with various chelating agents (EDTA, 1,10-o-phenanthroline, and pyridine-2,6-dicarboxylic acid) indicated that formation of a ternary enzyme-metal-chelator complex precedes metal removal from the zinc center of the protein and revealed notable differences in the inactivation parameters of VIM-1 with different agents.
引用
收藏
页码:3003 / 3007
页数:5
相关论文
共 29 条
[1]   A NOVEL INTEGRON-LIKE ELEMENT CARRYING THE METALLO-BETA-LACTAMASE GENE BLA(IMP) [J].
ARAKAWA, Y ;
MURAKAMI, M ;
SUZUKI, K ;
ITO, H ;
WACHAROTAYANKUN, R ;
OHSUKA, S ;
KATO, N ;
OHTA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1612-1615
[2]   Molecular characterization of a carbapenem-hydrolyzing β-lactamase from Chryseobacterium (Flavobacterium) indologenes [J].
Bellais, S ;
Léotard, S ;
Poirel, L ;
Naas, T ;
Nordmann, P .
FEMS MICROBIOLOGY LETTERS, 1999, 171 (02) :127-132
[3]   Metallo-β-lactamases:: A class apart [J].
Bush, K .
CLINICAL INFECTIOUS DISEASES, 1998, 27 :S48-S53
[4]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[5]   KINETIC-ANALYSIS OF EXTENSION OF SUBSTRATE-SPECIFICITY WITH XANTHOMONAS-MALTOPHILIA, AEROMONAS-HYDROPHILA, AND BACILLUS-CEREUS METALLO-BETA-LACTAMASES [J].
FELICI, A ;
AMICOSANTE, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) :192-199
[6]  
FELICI A, 1993, BIOCHEM J, V291, pA1
[7]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[8]   Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli [J].
Laraki, N ;
Franceschini, N ;
Rossolini, GM ;
Santucci, P ;
Meunier, C ;
de Pauw, E ;
Amicosante, G ;
Frère, JM ;
Galleni, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :902-906
[9]   Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate [J].
Lauretti, L ;
Riccio, ML ;
Mazzariol, A ;
Cornaglia, G ;
Amicosante, G ;
Fontana, R ;
Rossolini, GM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1584-1590
[10]   Acquired carbapenemases [J].
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (06) :673-676